Cirevetmab (ZTS-00521426) is a caninized monoclonal antibody specifically designed for targeting Canis lupus familiaris TGFB1. Classified as an immunoglobulin G2-kappa, this antibody serves as an immunomodulator, influencing cellular responses and immune regulation in therapeutic applications. Cirevetmab is engineered for high specificity and efficacy in modulating the biological activity of TGFB1, making it an essential tool for research in canine immunological disorders.
Cirevetmab (ZTS-00521426) is a caninized monoclonal antibody specifically designed for targeting Canis lupus familiaris TGFB1. Classified as an immunoglobulin G2-kappa, this antibody serves as an immunomodulator, influencing cellular responses and immune regulation in therapeutic applications. Cirevetmab is engineered for high specificity and efficacy in modulating the biological activity of TGFB1, making it an essential tool for research in canine immunological disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
